Oral Drug Effective for Rare WHIM Syndrome, Approved by FDA

https://ashpublications.org/ashclinicalnews/news/7930/oral-drug-effective-for-rare-whim-syndrome Oral Drug Effective for Rare WHIM Syndrome, Approved by FDA Treatment with mavorixafor reduced infection frequency, severity and duration of infections, and antibiotic use among individuals with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome in a phase III ­placebo-controlled clinical trial.